FTC to Roche: OK, go ahead and complete your $4.3B Spark buyout — we’re convinced now this isn’t anticompetitive

After putting Roche through multiple delays during a 10-month review, the FTC has determined that Roche isn’t spending $4.3 billion to buy Spark so it can destroy a potential competitor, or use it to replace one of their new blockbusters. And the pharma giant followed up soon after to say

Read the full article here

Related Articles